Search

everythinglearnresearchcommunity

for

Search:↓

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Cancer survivors need better skin care to improve their quality of life.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Using finasteride with TIP extends time off period for prostate cancer patients.

Ozone therapy might improve cancer treatment and reduce its side effects.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.